Earlier this week, Patricell's Carla Stemate attended the WMAHSN Health and Wealth Economic Summit on Innovation, Investment and Productivity.
Held at Birmingham’s NEC arena, the WMAHSN Health and Wealth Economic Summit focused on developing and encouraging the collaboration between industry representatives, academia and healthcare with the aim to translate research into clinical practice.
Identifying the gaps in provision and support, the Summit focused on how the mutually beneficial collaborations between the three very different sectors can be encouraged and supported to stimulate innovation in the UK life sciences sector.
In alignment with this vision, the Birmingham Health Partners are leading the development of a new Institute of Translational Medicine (ITM), a new clinical research facility built to extrapolate Birmingham’s excellent track record in clinical trials by increasing capacity and enabling more patients to be co-located alongside clinicians and researchers.
The ITM encourages the close collaborations of biotechnology firms as well as pharmaceutical firms with research projects and clinical trials to support and push the research forward, by creating an ecosystem where the facilities and expertise is available from the point of discovery to market.